Advertisement
Clinical Genitourinary Cancer Home
Advanced searchSave search
Editorial board| Volume 21, ISSUE 1, PA1, February 2023

Editorial Board

    DOI:https://doi.org/10.1016/S1558-7673(23)00018-6
    Editorial Board
    Previous ArticleDoes the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv–UroCCR 79 Study
    Next ArticleTable of contents
        This paper is only available as a PDF. To read, Please Download here.

        Article info

        Identification

        DOI: https://doi.org/10.1016/S1558-7673(23)00018-6

        Copyright

        ScienceDirect

        Access this article on ScienceDirect

        The content on this site is intended for healthcare professionals.


        We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
        Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


        RELX